newsfilter
← Latest News
PR Newswire·

Oramed Pharmaceuticals Issues Letter to Shareholders

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug...